Breaking News, Financial News

Financial Report: Kendle 3Q

Early Stage revenue was $10.8 million (-4%) and YTD was $27.2 million (+7%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle 3Q09 3Q Revenues: $133.8 million (-26%) 3Q Earnings: $8.8 million (-6%) YTD Revenues: $421.0 million (-19%) YTD Earnings: $12.9 million (-35%) Comments: Early Stage revenue was $10.8 million (-4%) and YTD was $27.2 million (+7%). Late Stage revenue was down 17% to $91.5 million in the quarter and down 14% to $284.7 million YTD. New business awards for the quarter totaled $137.2 million, up from $132 million in 2Q09. Contract cancellations for the quarter were $53.8 million ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters